This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: John Spencer Cook: Innovator in Pharmaceutical Chemistry
Introduction
John Spencer Cook is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target inflammatory conditions. His work has implications for the treatment of various diseases, showcasing the importance of innovation in healthcare.
Latest Patents
John Spencer Cook holds a patent for a benzenesulphonate salt of a morpholine urea derivative, which is utilized as a CCR-3 antagonist in the treatment of inflammatory conditions. This patent represents a critical advancement in the search for effective therapies for patients suffering from such ailments. He has 1 patent to his name, reflecting his commitment to research and development in this area.
Career Highlights
Cook is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His role there has allowed him to work on innovative solutions that address pressing health issues. His expertise in pharmaceutical chemistry has positioned him as a valuable asset to his team and the broader scientific community.
Collaborations
Throughout his career, John Spencer Cook has collaborated with esteemed colleagues, including Andrew John Walker and Mark Wilkinson. These partnerships have fostered an environment of creativity and innovation, leading to advancements in their respective fields.
Conclusion
John Spencer Cook exemplifies the spirit of innovation in pharmaceutical research. His contributions, particularly in the development of new therapeutic compounds, highlight the vital role inventors play in advancing healthcare solutions.